MedTrace Logo

Follow up of IFN Vs DAAs HCV SVR (IFDACS Study)

NCT02578693 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1210

Last updated 2025-03-24

No results posted yet for this study

Summary

The study is designed to provide long term clinical and virologic follow up in subjects infected with hepatitis C virus (HCV) who received interferon-based therapy or direct-acting antiviral agents (DAAs)-based therapy. This long term follow up study is observational and no treatment is provided for HCV infection.

Conditions

  • Chronic Hepatitis C Infection

Sponsors & Collaborators

  • Beijing 302 Hospital

    collaborator OTHER

  • Nanfang Hospital, Southern Medical University

    collaborator OTHER

  • Yamanashi Prefectural Central Hospital

    collaborator UNKNOWN

  • Humanity and Health Research Centre

    lead OTHER

Principal Investigators

  • George Lau, MD · Humanity & Health Medical Centre

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-15
Primary Completion
2024-07-31
Completion
2024-07-31

Countries

  • China
  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02578693 on ClinicalTrials.gov